ChristopherGNelsonMD

Associate Professor, Dermatology, USF-Morsani

Dr. Nelson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
12901 Bruce B Downs Blvd
MDC 79
Tampa, FL 33612
Phone+1 813-974-2201

Fax+1 727-821-1292

University of Texas Medical Branch HospitalsChief Residency, Dermatology, 1977 - 1977
University of Texas Medical Branch HospitalsResidency, Dermatology, 1974 - 1977
Indiana University School of Medicine/Ball MemorialInternship, Family Medicine, 1971 - 1972
Indiana University School of Medicine/Ball MemorialInternship, Transitional Year, 1971 - 1972
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1971
Cambridge UniversityClinical Clerkship, 1970 - 1970
University of IowaBS, 1964 - 1968

PubMed

28 citations
Diclofenac gel in the treatment of actinic keratoses.
Christopher G Nelson
Therapeutics and Clinical Risk Management. 2011-06-15
23 citations
Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation.
Christopher Nelson, Darrell S. Rigel
The Journal of Clinical and Aesthetic Dermatology. 2009-07-01
49 citations
Sentinel node biopsy for thin melanomas: which patients should be considered?
Christopher A. Puleo, Jane L. Messina, Adam I. Riker, L. Frank Glass, Christopher Nelson
Cancer Control. 2005-10-01

Journal Articles

Pemphigus Vegetans of Hallopeau: Immunoflorescent Studies.
Nelson CG, Apisarnthanarax P, Bean SF, Mullins JF, Arch Dermatol
Letter to the Editor.
Nelson CG, Arch Dermatol
Phase IV, Open Label Assessment of the Treatment of Actinic Keratosis With 3.0% Diclofenac Sodium Topical Gel (Solaraze).
Nelson CG, J Drugs Dermatol
A single-arm, open-label efficacy and tolerability study of diclofenav sodium 3% gel for actinic keratoses of the upper and lower lip.
Nelson CG, J Drugs Dermatol
Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One –year Evaluation.
Nelson CG, Rigel D, J Clin Aesthet Dermatol
Diclofenac gel in the treatment of actinic keratoses.
Nelson CG, Ther Clin Risk Manag
Acute Skin Problems.
Nelson, C.G., M.D, Florida Family Physician
Join now to see all

Books/Book Chapters

Lectures

Optimizing Sunscreens-A Multiphase Study Designed to Enhance The Photoprotection of Traditionally Formulated Products.
Exhibit American Academy of Dermatology
Optimizing Traditionally Formulated Sunscreens Using Inert Ingredients to Enhance Photoprotection.
American Academy of Dermatology Annual Meeting
Predicting Sun Protection Factor (SPF) – A Computer Model and a Method of In Vitro Analysis.
American Academy of Dermatology Annual Meeting
Blocking Ultraviolet Rays – What are the Optimum Concentrations of the FDA Approved Sunscreening Agents?
Society of Cosmetic Chemists International Suncsreen Symposium
Shifting Action Spectra: Manipulating Emulsions to Optimize Sunscreens.
Society of Cosmetic Chemists International Sunscreen Symposium
More Efficient Sunscreens: Using Inert Natural Extracts to Enhance Photoprotection.
American Academy of Dermatology Annual Meeting
Emulsions – Do Small Uniform Particles Correlate with Long Term Stability?
Society of Cosmetic Chemists International Sunscreen Symposium
Dertermining Action Spectra – What are the Absorption Curves of the FDA Approved Sunscreening Agents? Will Combining them Produce Synergy?
Society of Cosmetic Chemists International Sunscreen Symposium
Join now to see all